JPRN-jRCTs031220435招募中Unknown
Hot Flash Treatment for Women with Hormone Receptor-Positive Breast Cancer: Safety and Efficacy of Venlafaxine - HOFLA-V
Bando Hiroko0 个研究点目标入组 20 人开始时间: 2022年11月4日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 60age old（—）
- 性别
- Female
入选标准
- •(1) Patients aged between 18 and 60 at the time of consent
- •(2) Patients with stage 1-3C primary breast cancer
- •(3) Patients receiving tamoxifen for the adjuvant therapy with or without LH-RHagonists
- •(4) Patients with more than 14 hot flushes per week
- •(5) Eastern Cooperative Oncology Group Performance Status 0 or 1
- •(6) Patients who have agreed in writing to participate in this study after understanding this study an d who can adequately answer patient questionnaires.
排除标准
- •(1) Patients diagnosed with depression
- •(2) Patients undergoing treatment for thyroid disease
- •(3) eGFR less than 15 mL/min or dialysis patients
- •(4) Patients with severe liver dysfunction: Bilirubin total is over 2mg/dl or AST or ALT is over 100 U/L
- •(5) Patients using the following drugs.
- •selective serotonin reuptake inhibitor:SSRI, Serotonin Noradrenaline Reuptake Inhibitor:SNRI(except for venlafaxine), Strong or moderate CYP2D6 inhibitor, CYP3A inhibitors and CYP3A inducers, gabapentinoids, MAO inhibitors
- •(6) Patients who had allergic reaction to venlafaxine
- •(7) Other patients that the research doctor deems inappropriate
研究者
相似试验
已完成
2 期
Phenamate in the treatment of prostate cancerProstate cancer with resistance to castration.Prostatic Neoplasms, Castration-ResistantGenital Neoplasms, MaleUrogenital NeoplasmsProstatic DiseasesGenital Diseases, MaleMale Urogenital DiseasesProstatic NeoplasmsProstate cancerRPCEC00000248Medical School of the University of Colima, Mexico40
招募中
不适用
Acupuncture for Hot Flashes in Hormone-Receptor-Positive Breast CancerNeoplasmsKCT0003618The Catholic University of Daegu40
已完成
3 期
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast CancerHot FlashesBreast CancerMenopausal SymptomsNCT00026286Eastern Cooperative Oncology Group
进行中（未招募）
Unknown
Supporting women with adherence to hormone therapy following breast cancerBreast cancerCancerISRCTN24852890ewcastle upon Tyne Hospitals NHS Foundation Trust1,460
已完成
3 期
IBCSG 35-07 / BIG 1-07 : Study of Letrozole Extension (SOLE). Letrozole in Preventing the Return of Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer.Endocrine Responsive Breast CancerCancer - BreastACTRN12608000243314ovartis Pharma AG4,800